The ideal reperfusion strategy for the ST-segment elevation myocardial infarction patient with expected delay to percutaneous coronary intervention: paradise lost or paradise renamed?
Timothy D
TD
Henry
David M
DM
Larson
D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000401:mortality; D003131:Combined Modality Therapy; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006297:Health Services Accessibility; D006801:Humans; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D010360:Patient Transfer; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000401:mortality; D013997:Time Factors; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors